Exercise for women with triple-negative breast cancer
Part of Cancer, Skin clinical trials.
This study tests whether an exercise program can help women with triple-negative breast cancer during their chemotherapy treatment. You will be asked to participate in a supervised exercise routine while receiving your standard cancer drugs.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have triple-negative breast cancer that can be seen on an ultrasound.
- Your cancer is at an early stage that still can be treated with the goal of cure, with a certain size and lymph node spread.
- You are scheduled to receive a specific combination of chemotherapy and immunotherapy drugs.
- You are willing to use birth control if you could become pregnant (for up to 6-12 months after treatment).
- You can speak and understand German well enough to follow instructions.
- You do not have a heart or bleeding condition that would make exercise unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at whether a program of healthy eating and exercise, started during chemotherapy, can help shrink your tumor more effectively. You will be randomly assigned to either follow the diet and exercise plan or stick with your usual care.
This study tests whether supervised exercise during chemotherapy is safe and helpful for people with early-stage breast cancer. It may support physical function and well-being while you are receiving cancer treatment.
This study tests whether a new approach using a genetic test can guide treatment for low-risk triple-negative breast cancer. It aims to help patients avoid unnecessary chemotherapy while keeping the cancer from coming back.
This trial tests whether giving pembrolizumab (an immunotherapy drug) together with chemotherapy before surgery can help treat early-stage triple-negative breast cancer. It aims to improve outcomes by shrinking the tumor before removal.
This trial tests whether a special cycling exercise program during chemotherapy can help women with breast cancer. It is for patients who are about to start a common type of chemotherapy and want to add physical activity to their treatment plan.
This trial tests a combination of an immunotherapy drug (pembrolizumab) plus two chemotherapy drugs (carboplatin and paclitaxel) given before surgery for people with early-stage, triple-negative breast cancer. The goal is to see if this treatment helps shrink or eliminate the tumor before it's removed.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.